Also published in dealbook.nytimes.com:
More Officials Called to Testify on Duke Energy’s Boardroom Coup
x hide permanently

A Lesson for Boardroom Battles

dealbook.nytimes.com

Proxy access may be dead in the United States, but it lives in Israel, to the great regret of Taro Pharmaceutical Industries.  Taro is facing a proxy battle involving two external directors nominated by the asset management firm BlueMountain Capital Management. While unfortunate for Taro, it all shows an alternative universe of what, for better or worse, could have happened had proxy access been in place in the United States...

Mentions: Proxy Advisory Management activist investors